Johnson & Johnson invests Series A funding of TECLens, a refractive technology start-up that is developing a novel, non-incisional refractive correction procedure that leverages a technique known as corneal cross-linking to reshape the cornea. According to J&J, this investment in the early-stage start-up furthers a commitment to innovation in ophthalmology and broadening its portfolio of refractive technologies. “This move, encouraging early innovation, partnering with experts and leveraging new technology is how we continue to improve outcomes for patients” said Peter Menziuso, company group chairman, Vision, J&J.

September 2024